
Divorate 250mg Tablet ER
Marketer
Estro Pharmaceuticals
Salt Composition
Divalproex (250mg)
Overview Divorate 250mg Tablet ER
Epileptin 250mg Extended-Release tablets are prescribed for epilepsy management, effectively preventing and controlling seizures. They are also indicated for migraine prophylaxis and, in some cases, bipolar disorder treatment. Epileptin 250mg ER can be administered alone or in conjunction with other medications; dosage and frequency are determined individually by your physician to optimize symptom control. This medication may be taken with or without food, but consistent daily timing is crucial for maximum therapeutic effect. Onset of action typically occurs within a few weeks. Continuous use, as directed, is vital; missed doses can precipitate seizures, and abrupt cessation may exacerbate the underlying condition. Gradual discontinuation is essential. Common side effects include headache, visual blurring, nausea, vomiting, dizziness, fatigue, instability, easy bruising, and hypothermia. Most are mild and transient; however, persistent or bothersome effects should be reported to your doctor. Immediate medical attention is warranted if a skin rash or redness develops. Prolonged use can potentially lead to osteoporosis and increased fracture risk. Suicidal ideation and behavior are rare but possible adverse events; report any depressive mood changes promptly. Prior to initiating Epileptin 250mg ER, inform your doctor of any pre-existing cardiac conditions, renal or hepatic impairment, urinary difficulties, depression history, or suicidal tendencies. Potential drug interactions are significant; disclose all current medications to ensure safe concurrent use. If pregnant, consult your doctor before starting or stopping this medication. Alcohol consumption should be minimized due to its potential to intensify side effects and increase seizure risk. Regular blood tests, both pre- and post-treatment, may be required for optimal dose adjustment.
Uses of Divorate 250mg Tablet ER
Managing epileptic seizures and bipolar disorder, plus migraine prevention.
Major Benefits of Divorate 250mg Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 250mg extended-release tablet (Divorate) can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Divorate 250mg Tablet ER:
- Decreased body temperature
- Dizziness
- Sleepiness
- Tremors
- Paresthesia (tingling or pricking sensation)
- Anemia (low number of red blood cells)
- Decreased sodium level in blood
- Liver injury
- Gastrointestinal disturbance
- Hypersensitivity
- Deafness
- Urinary incontinence
- Increase in body weight
- Pain during periods
How to use Divorate 250mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 250mg extended-release tablet can be consumed with or without food, though consistent timing is recommended.
How Divorate 250mg Tablet ER works:
Epileptic seizures are managed by Divorate 250mg Extended-Release tablets, an anticonvulsant drug that reduces heightened, irregular neuronal firing in the brain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Divorate 250mg extended-release tablets and alcohol can lead to significant sedation.
PregnancyCONSULT YOUR DOCTOR
Extended-release Divorate 250mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Extended-release Divorate 250mg tablets pose minimal breastfeeding risk. Research in humans indicates negligible drug transfer to breast milk, presenting no apparent infant harm.
DrivingUNSAFE
Extended-release Divorate 250mg tablets can induce adverse reactions that may impair driving ability.
KidneySAFE IF PRESCRIBED
Extended-release Divorate 250mg tablets pose no safety concerns for individuals with kidney impairment; dosage modification is unnecessary.
LiverUNSAFE
Extended-release Divorate 250mg tablets pose a likely risk for individuals with hepatic impairment and should be omitted. Physician consultation is recommended.
What if you forget to take Divorate 250mg Tablet ER :
Should you forget a Divorate 250mg Extended-Release Tablet, take it immediately upon remembering. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Divorate 250mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Derivatives of Aliphatic Carboxylic Acids |
| Developing Habits | No. |
| Type of Therapy | Central Nervous System (CNS) Neuro |
| Action Class | Antiepileptic drugs targeting sodium channels |
